Intelligent Bio Solutions Inc. (INBS)
INBS trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2026-06-30, https://www.sec.gov/Archives/edgar/data/1725430/000149315226039136/0001493152-26-039136-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-06-30.
Profile
| Field | Value |
|---|---|
| Ticker | INBS on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001725430 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2026
| Line | Value |
|---|---|
| Revenue | $4.2M |
| Net income | -$12.4M |
| Operating income | -$12.6M |
| Net margin | -294.9% |
| Operating margin | -299.1% |
| Revenue growth | +38.1% |
| Cash | $4.0M |
| Total assets | $11.9M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.2× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "Accordingly, these factors raise substantial doubt about the Company's ability to continue as a going concern." | 10-Q 2026-11-10 |
| Cash and burn | $5.9M cash; operating cash flow -$3.0M a quarter. | Report 2026-09-30 |
| Shares outstanding | 3,316,803 (2026-11-10); 9,452,553 a year earlier; 8,734,381 three years earlier. 1y figure adjusted for splits (1-for-10 overall); 3y figure adjusted for splits (1-for-120 overall). | Cover page 2026-11-10 |
| Reverse splits, 3 years | 2; latest 1-for-10 on 2025-12-16 | Source 2025-12-16 |
| Shelf and offerings, 12 months | 2 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the market | Latest 2026-03-23 |
| Exchange deficiency notices, 12 months | 1 (8-K item 3.01) | 8-K 2025-12-16 |
| Auditor | UHY LLP, Melville, New York, United States | PCAOB Form AP 2026-08-28 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q1 2027 2026-09-30 | $1.4M | -$2.7M | -$2.8M | $5.9M | No debt tags | $4.5M | 10-Q 2026-11-10 |
| Q4 2026 2026-06-30 | $1.1M | -$3.9M | -$3.2M | $4.0M | $0 | $4.2M | 10-K 2026-08-19 |
| Q3 2026 2026-03-31 | $1.1M | -$2.9M | -$4.3M | $6.9M | No debt tags | $3.9M | 10-Q 2026-05-13 |
| Q2 2026 2025-12-31 | $897K | -$2.7M | -$1.6M | $740K | $13K | $3.8M | 10-Q 2026-02-12 |
| Q1 2026 2025-09-30 | $1.1M | -$3.0M | -$2.8M | $1.7M | $140K | $3.6M | 10-Q 2026-11-10 |
| Q4 2025 2025-06-30 | $844K | -$3.1M | -$2.2M | $1.0M | $197K | $3.5M | 10-K 2026-08-19 |
| Q3 2025 2025-03-31 | $902K | -$2.5M | -$2.8M | $2.8M | $356K | $3.4M | 10-Q 2025-05-13 |
| Q2 2025 2024-12-31 | $741K | -$2.2M | -$2.3M | $2.2M | $406K | $3.4M | 10-Q 2025-02-13 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-09-23 |
| Latest annual report | 10-K/A | 2026-10-21 |
| Latest quarterly / interim | 10-Q | 2026-11-10 |
| Latest current report | 8-K | 2026-11-10 |
| Latest proxy | DEF 14A | 2026-11-02 |
Source: SEC EDGAR submissions feed, 469 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -10.7% |
| 1 month | +18.9% |
| 3 months | -41.3% |
| Year to date | -81.5% |
| 1 year | -75.5% |
| From 52-week high | -90.2% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ICU | SeaStar Medical Holding Corporation | $0.8535 | +1.80% | $4.5M |
| BDMD | Baird Medical Investment Holdings Ltd Ordinary Share | $0.1065 | +17.68% | $4.5M |
| WOK | WORK Medical Technology Group LTD | $1.23 | +2.50% | $5.5M |
| SNOA | Sonoma Pharmaceuticals Inc. | $0.8802 | -19.25% | $4.5M |
| NVNO | enVVeno Medical Corporation | $5.95 | -3.65% | $4.1M |
| NMTC | NeuroOne Medical Technologies Corporation | $0.7450 | -0.01% | $6.8M |
| TNON | Tenon Medical Inc. | $1.33 | -5.32% | $3.6M |
| CNSY | Cerenome Inc. Common Stock | $0.7148 | -24.77% | $7.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier